Wird geladen...

Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer

The AGO Kommission Ovar already published a statement in 2013, warning about the uncritical use of hyperthermic intraperitoneal chemotherapy (HIPEC) outside controlled studies. This statement has now been updated after the most recent literature was reviewed by AGO Kommission Ovar, the AGO Study Gro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Geburtshilfe Frauenheilkd
Hauptverfasser: Harter, P., du Bois, A., Mahner, S., Pfisterer, J., Ortmann, O., Marth, C., Fink, D., Hilpert, F., Wagner, U., Sehouli, J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Georg Thieme Verlag KG 2016
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4771502/
https://ncbi.nlm.nih.gov/pubmed/26941446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0035-1568169
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!